80 related articles for article (PubMed ID: 37453833)
1. Long-term remission of infantile Takayasu arteritis associated with germline CBL syndrome after allogeneic hematopoietic stem cell transplantation: A case report and literature review.
Munoz-Osores E; Piñones M; Barriga F; Wietstruck MA; Pérez-Mateluna G; Mellado C; Aracena M; Parra R; García C; Borzutzky A
Transpl Immunol; 2024 Apr; 83():102013. PubMed ID: 38395087
[TBL] [Abstract][Full Text] [Related]
2. [Suspicion of constitutional abnormality at diagnosis of childhood leukemia: Update of the leukemia committee of the French Society of Childhood Cancers].
Strullu M; Cousin E; de Montgolfier S; Fenwarth L; Gachard N; Arnoux I; Duployez N; Girard S; Guilmatre A; Lafage M; Loosveld M; Petit A; Perrin L; Vial Y; Saultier P
Bull Cancer; 2024 Mar; 111(3):291-309. PubMed ID: 38267311
[TBL] [Abstract][Full Text] [Related]
3. Vaccines: a promising therapy for myelodysplastic syndrome.
Gera K; Chauhan A; Castillo P; Rahman M; Mathavan A; Mathavan A; Oganda-Rivas E; Elliott L; Wingard JR; Sayour EJ
J Hematol Oncol; 2024 Jan; 17(1):4. PubMed ID: 38191498
[TBL] [Abstract][Full Text] [Related]
4. Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M.
Gurnari C; Gagelmann N; Badbaran A; Awada H; Dima D; Pagliuca S; D'Aveni-Piney M; Attardi E; Voso MT; Cerretti R; Wolschke C; Rubio MT; Maciejewski JP; Kröger N
Leukemia; 2023 Mar; 37(3):717-719. PubMed ID: 36709353
[No Abstract] [Full Text] [Related]
5. Myelodysplasia in younger adults: outlier or unique molecular entity?
Sallman DA; Padron E
Haematologica; 2017 Jun; 102(6):967-968. PubMed ID: 28566339
[No Abstract] [Full Text] [Related]
6. Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults.
Brown A; Batra S
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473358
[TBL] [Abstract][Full Text] [Related]
7. Refining risk stratification to improve prognosis in juvenile myelomonocytic leukemia.
Nunn JL; Fraser CJ
Haematologica; 2024 May; ():. PubMed ID: 38813703
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumor-only
Newman H; Clark ME; Wong D; Wu J; Brodeur GM; Hunger SP; Tasian SK; Olson T; Warren JT; Teachey DT; Bona K; Schubert J; Golenberg N; Patel M; Denenberg EH; Fanning EA; Chen J; Luke T; Charles S; Gallo D; Cao K; Fu W; Fan Z; Surrey LF; Wertheim G; Luo M; MacFarland SP; Li MM; Zhong Y
Haematologica; 2024 Feb; ():. PubMed ID: 38385299
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Applications of Azanucleoside Analogs as DNA Demethylating Agents.
Gallimore F; Fandy TE
Epigenomes; 2023 Jul; 7(3):. PubMed ID: 37489400
[TBL] [Abstract][Full Text] [Related]
10. Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress.
Venugopal S; Shallis RM; Zeidan AM
Expert Rev Anticancer Ther; 2023; 23(9):903-911. PubMed ID: 37470508
[TBL] [Abstract][Full Text] [Related]
11. Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future.
Choi JH; Shukla M; Abdul-Hay M
Acta Haematol; 2023; 146(6):431-457. PubMed ID: 37459852
[TBL] [Abstract][Full Text] [Related]
12. Recent updates in the indolent lymphomas: Update on marginal zone lymphoma and Waldenström's macroglobulinemia.
Amaador K; Thieblemont C; Trotman J; Minnema MC
Hematol Oncol; 2023 Jul; ():. PubMed ID: 37458281
[TBL] [Abstract][Full Text] [Related]
13. [MDS & CMML: Diagnostic and classification].
Wagner-Ballon O; Kosmider O
Bull Cancer; 2023 Nov; 110(11):1106-1115. PubMed ID: 37453834
[TBL] [Abstract][Full Text] [Related]
14. [Juvenile myelomonocytic leukemia and pediatric myelodysplastic syndromes].
Strullu M; Leblanc T; Lainey E
Bull Cancer; 2023 Nov; 110(11):1183-1195. PubMed ID: 37453833
[TBL] [Abstract][Full Text] [Related]
15. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
[TBL] [Abstract][Full Text] [Related]
16. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Flotho C; Sommer S; Lübbert M
Semin Cancer Biol; 2018 Aug; 51():68-79. PubMed ID: 29129488
[TBL] [Abstract][Full Text] [Related]
17. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
Niemeyer CM; Kratz CP
Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
[TBL] [Abstract][Full Text] [Related]
18. Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia.
Loh ML
Hematology Am Soc Hematol Educ Program; 2010; 2010():357-62. PubMed ID: 21239819
[TBL] [Abstract][Full Text] [Related]
19. Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.
Chang TY; Dvorak CC; Loh ML
Blood; 2014 Oct; 124(16):2487-97. PubMed ID: 25163700
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
